首页> 外文会议>Nano Science and Technology Institute(NSTI) Nanotechnology Conference and Trade Show(NSTI Nanotech 2007) vol.2; 20070520-24; Santa Clara,CA(US) >An Implantable Drug Delivery Device based on MEMS Technology for Treatment of Hemorrhagic Shock on the Battlefield
【24h】

An Implantable Drug Delivery Device based on MEMS Technology for Treatment of Hemorrhagic Shock on the Battlefield

机译:一种基于MEMS技术的植入式给药装置,用于治疗战场失血性休克

获取原文
获取原文并翻译 | 示例

摘要

A novel drug delivery system based on MEMS (Micro-Electro-Mechanical-Systems) technology was developed for the immediate treatment of hemorrhagic shock of soldiers affected on the battlefield. A miniaturized drug delivery system was developed and implemented as an implantable biochip capable of delivering vasopressin in vivo, a known vasoconstrictor, in 0.02-0.1 ml volumes. Such implantable biochip was specially tailored to treat hemorrhagic shock in ambulatory settings. The biochip MEMS design allows controlled release of the drug. The biochip design is intended for in vivo use as a micro-implant in the peritoneum. We believe that the ramifications of this new MEMS-based drug delivery system can also be applicable to a vast number of medical applications for civilian use.
机译:开发了一种基于MEMS(微机电系统)技术的新型药物输送系统,用于立即治疗战场上受影响的士兵的失血性休克。开发了微型药物递送系统,并将其实现为可植入生物芯片,该生物芯片能够以0.02-0.1 ml的体积在体内递送血管加压素(一种已知的血管收缩剂)。这种可植入的生物芯片专门为在非卧床环境中治疗失血性休克而设计。生物芯片MEMS设计允许药物的受控释放。该生物芯片设计旨在体内用作腹膜中的微型植入物。我们相信,这种新的基于MEMS的药物输送系统所产生的影响也可以应用于大量民用医疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号